190 related articles for article (PubMed ID: 38673990)
1. Review of Patient Gene Profiles Obtained through a Non-Negative Matrix Factorization-Based Framework to Determine the Role Inflammation Plays in Neuroblastoma Pathogenesis.
Boccarelli A; Del Buono N; Esposito F
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673990
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma.
Takita J; Ishii M; Tsutsumi S; Tanaka Y; Kato K; Toyoda Y; Hanada R; Yamamoto K; Hayashi Y; Aburatani H
Genes Chromosomes Cancer; 2004 Jun; 40(2):120-32. PubMed ID: 15101045
[TBL] [Abstract][Full Text] [Related]
3. Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients.
Nevo I; Oberthuer A; Botzer E; Sagi-Assif O; Maman S; Pasmanik-Chor M; Kariv N; Fischer M; Yron I; Witz IP
Int J Cancer; 2010 Apr; 126(7):1570-81. PubMed ID: 19739072
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
[TBL] [Abstract][Full Text] [Related]
5. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
6. Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication.
Wolf M; Korja M; Karhu R; Edgren H; Kilpinen S; Ojala K; Mousses S; Kallioniemi A; Haapasalo H
BMC Cancer; 2010 May; 10():181. PubMed ID: 20444257
[TBL] [Abstract][Full Text] [Related]
7. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.
Alaminos M; Davalos V; Cheung NK; Gerald WL; Esteller M
J Natl Cancer Inst; 2004 Aug; 96(16):1208-19. PubMed ID: 15316056
[TBL] [Abstract][Full Text] [Related]
8. IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma.
Bell JL; Turlapati R; Liu T; Schulte JH; Hüttelmaier S
J Clin Oncol; 2015 Apr; 33(11):1285-93. PubMed ID: 25753434
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients.
Suo C; Deng W; Vu TN; Li M; Shi L; Pawitan Y
Biol Direct; 2018 Jul; 13(1):14. PubMed ID: 30012197
[TBL] [Abstract][Full Text] [Related]
10. Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study.
Rifatbegovic F; Abbasi MR; Taschner-Mandl S; Kauer M; Weinhäusel A; Handgretinger R; Ambros PF
PLoS One; 2015; 10(9):e0137995. PubMed ID: 26360775
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of cell cycle genes distinguishes aggressive neuroblastoma.
Krasnoselsky AL; Whiteford CC; Wei JS; Bilke S; Westermann F; Chen QR; Khan J
Oncogene; 2005 Feb; 24(9):1533-41. PubMed ID: 15592497
[TBL] [Abstract][Full Text] [Related]
12. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
[TBL] [Abstract][Full Text] [Related]
13. The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines.
Fardin P; Barla A; Mosci S; Rosasco L; Verri A; Varesio L
BMC Genomics; 2009 Oct; 10():474. PubMed ID: 19832978
[TBL] [Abstract][Full Text] [Related]
14. Reverse engineering the neuroblastoma regulatory network uncovers MAX as one of the master regulators of tumor progression.
Albanus RD; Juliani Siqueira Dalmolin R; Alves Castro MA; Augusto de Bittencourt Pasquali M; de Miranda Ramos V; Pens Gelain D; Fonseca Moreira JC
PLoS One; 2013; 8(12):e82457. PubMed ID: 24349289
[TBL] [Abstract][Full Text] [Related]
15. MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S.
Bénard J; Raguénez G; Kauffmann A; Valent A; Ripoche H; Joulin V; Job B; Danglot G; Cantais S; Robert T; Terrier-Lacombe MJ; Chassevent A; Koscielny S; Fischer M; Berthold F; Lipinski M; Tursz T; Dessen P; Lazar V; Valteau-Couanet D
Mol Oncol; 2008 Oct; 2(3):261-71. PubMed ID: 19383347
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiles in neuroblastoma: Differences in risk and histology groups.
Ergin K; Aktaş S; Altun Z; Dınız G; Olgun N
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e374-e379. PubMed ID: 29115037
[TBL] [Abstract][Full Text] [Related]
17. Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.
Coulon A; Flahaut M; Mühlethaler-Mottet A; Meier R; Liberman J; Balmas-Bourloud K; Nardou K; Yan P; Tercier S; Joseph JM; Sommer L; Gross N
Neoplasia; 2011 Oct; 13(10):991-1004. PubMed ID: 22028624
[TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma.
Schulte JH; Eggert A
Crit Rev Oncog; 2015; 20(3-4):245-70. PubMed ID: 26349419
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of high-risk neuroblastoma by cDNA array.
Sardi I; Tintori V; Marchi C; Veltroni M; Lippi A; Tucci F; Tamburini A; Bernini G; Faulkner L
Int J Mol Med; 2002 May; 9(5):541-5. PubMed ID: 11956663
[TBL] [Abstract][Full Text] [Related]
20. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes.
De Preter K; Vandesompele J; Heimann P; Yigit N; Beckman S; Schramm A; Eggert A; Stallings RL; Benoit Y; Renard M; De Paepe A; Laureys G; Påhlman S; Speleman F
Genome Biol; 2006; 7(9):R84. PubMed ID: 16989664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
